Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities

RECOMMENDED

HypertensionLipid-Lowering DrugsThrombosis and Stroke

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial

Lancet.

Gupta A, Mackay J, Whitehouse A, Godec T, Collier T, Pocock S, Poulter N, Sever P

doi: 10.1016/S0140-

Heart, Artery and Coronary Diseases

D-dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events and Cancer in Stable Coronary Heart Disease Patients: The LIPID Study

Circulation.

Simes J, Robledo KP, White HD, Espinoza D, Stewart RA, Sullivan DR, Zeller T, Hague W, Nestel PJ, Glasziou PP, Keech AC, Elliott J, Blankenberg S, Tonkin AM; LIPID study investigators

doi: 10.1161/CIRCULATIONAHA.

Heart, Artery and Coronary Diseases

Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy

J Am Coll Cardiol.

Cui H, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR

doi: 10.1016/j.jacc.2019.05.053.

Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesHeart FailureHypertension

The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial

Eur Heart J.

Andersson B, She L, Tan RS, Jeemon P, Mokrzycki K, Siepe M, Romanov A, Favaloro LE, Djokovic LT, Raju PK, Betlejewski P, Racine N, Ostrzycki A, Nawarawong W, Das S, Rouleau JL, Sopko G, Lee KL, Velazquez EJ, Panza JA; STICH Trial Investigators

doi: 10.1093/eurheartj/ehy438.

Heart, Artery and Coronary DiseasesHeart Failure

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study

Eur Heart J.

Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kindermann I, Kühl U, Angermann CE, Schlitt A, Fischer D, Podewski E, Böhm M, Sliwa K, Bauersachs J

doi: 10.1093/eurheartj/ehx355.

Cardiac Arrest or Death

Postoperative Myocardial Injury in Patients Classified as Low Risk Preoperatively Is Associated With a Particularly Increased Risk of Long-Term Mortality After Noncardiac Surgery

J Am Heart Assoc

Vasireddi SK, Pivato E, Soltero-Mariscal E, Chava R, James LO, Gunzler D, Leo P, Kondapaneni MD

doi: 10.1161/JAHA.120.019379

Cardiovascular Risk and Diseases

Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality: 46 Years of Follow-Up

J Am Coll Cardiol.

Clausen JSR, Marott JL, Holtermann A, Gyntelberg F, Jensen MT

doi: 10.1016/j.jacc.2018.06.045.

Cardiovascular Risk and DiseasesLipid-Lowering Drugs

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study

Lancet Diabetes Endocrinol.

Raal FJ, Hovingh GK, Blom D, Santos RD, Harada-Shiba M, Bruckert E, Couture P, Soran H, Watts GF, Kurtz C, Honarpour N, Tang L, Kasichayanula S, Wasserman SM, Stein EA

doi: 10.1016/S2213-8587

Cardiac Arrest or Death

Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular Morbidity

JAMA Pediatr

Tidblad A, Bottai M, Kieler H, Albertsson-Wikland K, Sävendahl L

doi: 10.1001/jamapediatrics.2020.5199

Related content